Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

MYSTERIOUS: 23 - What They Never Told You

Citi analyst Charles J Armitage upgraded the aerospace and defense firm Boeing Co (NYSE:BA) to Buy/High Risk from Neutral and lowered the price target to $209 (implying an upside of 56.3%) from $219. The analyst seeks to value Boeing on the assumption that the (significant) medium-term risks can be mitigated while also quantifying those risks.…

Benzinga

Citi Reiterated Neutral Rating On Intel, AMD - Read Why

Citi analysts Christopher Danely and Kelsey Chia observed that May notebook shipments were up 22% month on month, below Citi's expectation of up 29% due to demand deceleration. This is the fifth consecutive month where notebook shipments were below expectations.

Benzinga

Cosmetics Maker Revlon Nears Chapter 11 Filing

Revlon Inc. is preparing to file for chapter 11 protection as soon as this week after struggling for years with too much debt, stiff competition in the cosmetics business and more recent inflation and supply-chain pressures, people familiar with the matter said.

Bangkok Post

From analysis to the latest developments in health,
read the most diverse news in one place.

Here's Why Citi Is Incrementally Bullish On FleetCor, WEX

Citi analyst Peter Christiansen expressed incremental bullishness on FleetCor Technologies, Inc (NYSE:FLT) and WEX Inc (NYSE:WEX), lifting estimates and target prices on both, given rising fuel prices and solid demand signs. As a reminder, the incremental flow-through on higher fuel was highly margin-accretive. Christiansen upgraded WEX from Neutral to Buy on higher fuel and increased…

Benzinga

Read Why Citi Remains Bearish On Oxford Industries

Citi analyst Paul Lejuez raised the price target on Oxford Industries Inc (NYSE: OXM) to $92 (6% downside) from $86. Meanwhile, the analyst kept the Sell rating on the shares.

Benzinga

Intel Goes On Austerity Drive To Take On Rivals Like TSMC

Intel Corp (NASDAQ: INTC) has paused hiring in the PC desktop and laptop chips division as part of cost-cutting measures, Reuters reports. In its most recent quarter, Intel's client computing group raked $9.3 billion of its $18.4 billion in revenue. Intel could resume some hires within two weeks after the division re-evaluates priorities to…

Benzinga

Citi Sees Intel's Bear Case Taking Shape Sooner Than Expected

At a competitor conference on June 7, Intel Corp (NASDAQ:INTC) appeared to talk down the quarter as company management mentioned that circumstances were worse than expected during the quarter due to reduced inventory levels at customers and delays in normalization post-COVID lockdowns in China. Previously, Citi published multiple updates on flagging PC…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Citi Recommends Nvidia, Marvell To Seek Refuge Amid Semiconductor Downturn

Citi hosted meetings at NVIDIA Corp (NASDAQ:NVDA), Applied Materials, Inc (NASDAQ:AMAT), and Marvell Technology, Inc (NASDAQ:MRVL) as part of the Annual Silicon Valley Tech Bus Tour. Marvell confirmed a lack of slowdown in cloud data center demand and a disproportionate amount of growth or 50%+ coming from new product cycles. Applied Materials looked to benefit from…

Benzinga

Citi Aggressively Chases Growth In Asia, Especially China Amid Odds

In an interview with Reuters, Citigroup, Inc (NYSE:C) Asia chief shared plans to appoint 3,000 new employees for its Asia institutional business in the next few years. Asia became a battlefield for global banks chasing its vast economies, growing wealth, and relative growth beat most other places. Peter Babej saw the accumulated wealth…

Benzinga

Citigroup Looks To Hire Over 4K Tech Specialists To Tap Pandemic Induced Digital Boom

Citigroup, Inc (NYSE:C) looks to hire over 4,000 tech staff to help shift its institutional clients online following the pandemic, Bloomberg quoted from an interview with Jonathan Lofthouse. The head of markets and enterprise risk technology acknowledged that over 1,000 recruits would join the market technology team under an aggressive growth strategy. It…

Benzinga

Citi's Fat-Finger Gaffe Could Cost It Over $50M

Citigroup, Inc (NYSE:C) could cough up losses of over $50 million following a London-based worker's fat-finger trade, causing a flash crash in European stocks in May, Reuters reports. Citi is still tallying losses from the erroneous trade, and the final figure could further mount. A trader in the London's Delta One trading…

Benzinga

Shocking moment a gust of wind almost knocked over world's 7th tallest building

In 1978 an undergraduate student at Princeton University cold called an architect’s office and helped prevent one of the world’s tallest buildings from being knocked over in New York

Daily Mirror

Should You Use a Credit Card Travel Portal?

Some credit cards come with travel portals, where you can redeem points and miles for trips. Is it the best option?

Kiplinger

3 Warren Buffett Bank Stocks That Yield More Than 3%

Concerns over heightened inflation pressures and the Federal Reserve's aggressive interest rate hikes have increased volatility. Given recession concerns, dividend stocks ensure a regular income stream and could be wise. Thus, Warren Buffett's dividend-paying bank stocks, The Bank of New York (BK), Citigroup (C), and U.S. Bancorp (USB), could be…

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Here's Why Citi Remains Bullish On Amazon Despite Knocking It Off Focus List

Citi analyst Ronald Josey considers Amazon.com Inc (NASDAQ: AMZN) vulnerable to softening consumer spending trends.

Benzinga

Warren Buffett Exits Wells Fargo And Buys Stake In Its Rival Bank

Berkshire Hathaway Inc (NYSE: BRK-B) bought $3 billion worth of shares in Citigroup Inc (NYSE: C) in Q1, giving the group a stake of about 2.8%, according to filings with regulators.

StockNews.com

Citigroup: Buy, Sell, or Hold?

The shares of the renowned megabank Citigroup (C) have slumped more than 20% in price this year. Furthermore, with geopolitical issues taking a toll on the global economy and Wall Street seeing a risk of default by major banks, is C a smart investment now? Read on.

StockNews.com

Better Buy for 2022: Citibank vs. JPMorgan Chase

In this article I will analyze and compare Citigroup (C) and JPMorgan Chase (JPM) to determine which stock is currently a better investment.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Google Jumps The Crypto Bandwagon To Win Cloud Market From Alibaba, Amazon, Microsoft

Alphabet Inc’s (NASDAQ:GOOG) (NASDAQ:GOOGL) Google cloud unit formed a team to build services for developers running blockchain applications to tap the budding crypto market, CNBC reports. Former Citi executive James Tromans, who arrived at Google in 2019, will lead the product and engineering group. Google wants to offer back-end services to developers…

The Guardian - UK

Citigroup says trader made error behind ‘flash crash’ in Europe

Inputting mistake led to suspension of trading on several markets after sudden steep falls

Benzinga

Galera Posts Topline Data From Avasopasem Study In Chemoradiotherapy-Induced Esophagitis

Galera Therapeutics Inc (NASDAQ:GRTX) announced topline results from Phase 2a AESOP trial of avasopasem for severe acute radiation-induced esophagitis in lung cancer patients receiving concurrent chemoradiotherapy. Esophagitis is an early side effect of radiation or chemoradiation, causing pain, difficulties in swallowing with potential malnutrition, and dehydration. The trial enrolled 39 patients with unresectable…

Benzinga

Here's Why Analysts Remained Bullish On Western Digital Post Q3

Analysts reiterated their ratings on Western Digital Corporation's (NASDAQ: WDC)

Benzinga

Here's How Analysts Responded To Mastercard's Q1

Analysts maintained their conviction on Mastercard Incorporated (NYSE: MA)

Benzinga

Morning Brief: Top Financial Stories Dominating on Wednesday, April 27

Reuters Kellogg Sues British Government Over New Sugar Rules

Benzinga

FDA Plans To Convene AdComm For Ardelyx's Tenapanor For CKD Patients On Dialysis

The FDA's Office of New Drugs (OND), Center for Drug Evaluation and Research (CDER), has provided an interim response to Ardelyx Inc's (NASDAQ:ARDX) second level of appeal of the Complete Response Letter (CRL) for Xphozah. Ardelyx is seeking approval for Xphozah to control serum phosphorus in adult patients with chronic kidney disease (CKD) on…

1 … 22 23 24 25

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.